Fact Sheets Jul 16, 2026 Manufacturer Effectuation of MFP Draft Guidance for 2028 Medicare Drug Price Negotiation Medicare Drug Price Negotiation Program: Draft Guidance for Manufacturer Effectuation of the Maximum Fair Price in 2028 On July 16, 2026, the Centers for Medicare & Medicaid Services (CMS) issued program guidance that provides interested parties with detailed processes and requirements for Read more about Manufacturer Effectuation of MFP Draft Guidance for 2028 Medicare Drug Price Negotiation
US CMS Newsroom · July 16, 2026
Manufacturer Effectuation of MFP Draft Guidance for 2028 Medicare Drug Price Negotiation
CMS issued draft guidance on processes and requirements for manufacturers to implement maximum fair prices in the 2028 Medicare drug price negotiation program.
Published by US CMS Newsroom. HealthSignal links to the original document; the summary above is extracted from the source text.